Field Guides

Every cell preparation contains some level of debris—fragments from lysed cells, extracellular matrix remnants, aggregates, and other particulate matter—that quietly skews counts and downstream results.

Every hour spent optimizing viability dye concentrations is an hour not spent on your actual experiments. It's optimized for use - that's the important thing. You don't have to optimize it as a customer. Pre-optimized viability reagents eliminate the titration experiments, the incubation testing, the cell-type-specific protocol development. Why spend time optimizing when validated performance is available from the first use?

Most of the issue with viability reagents is that most people don't even know they exist. If you're running viability assays on Moxi V or Moxi GO II with generic dyes you optimized yourself, there's a better option you may not have heard about: pre-optimized, ready-to-use viability reagents designed specifically for your instrument. Now you know.

Single-cell genomics platforms capture transcripts from individual cells to reveal heterogeneity that bulk methods miss. That resolution depends on clean single-cell suspensions, where ambient RNA from lysed cells can contaminate every droplet.

Consider a simple 1:100 dilution from stock. Errors can enter at multiple points—stock measurement, diluent measurement, mixing adequacy, transfer losses—and each step compounds into measurable variability.

Most researchers assume that adding viability stains improves the accuracy of their cell counts. After all, you're adding more information—shouldn't that make the measurement better? The reality is more complicated.

Searching for viability protocols, adapting literature methods, trial-and-error until something works - this is time you don't need to spend. The user manual is designed to be super easy. Concentration-based instructions tell you exactly what to do: put X amount of viability reagent and put X amount of sample, incubate and go. No protocol hunting required.

A protocol can achieve high cell yield while producing low cell viability. Aggressive dissociation that frees many cells may simultaneously damage or kill them—a blindspot that viability assessment exposes.

That's why people - including me - just buy premixed gel loading dye and don't make my own from powder like my PI wanted me to. The same logic applies to viability reagents. Buy the damn gels rather than making them - consistency and data. When convenience and consistency matter more than tradition, pre-made beats DIY.

Every laboratory has protocols for cell culture, staining, and instrument operation. But ask about sample quality standards—specifically, debris thresholds—and you'll often find a blind spot where a QC checkpoint should be.

Using an aperture much larger than necessary reduces sizing resolution by creating smaller signal differences between cell sizes. Cell populations that should be distinguishable appear merged when the aperture is too large for the cells being measured. Target 15-40% of aperture diameter for optimal resolution. If you're counting lymphocytes on M+ cassettes because it works, you're sacrificing the sizing resolution that S+ cassettes would provide.

When you make your own viability reagents, every batch is different. When you buy pre-optimized reagents with QC'd lot consistency, every lot performs the same. Long-term experiments need long-term consistency - and that consistency comes from manufacturing quality control, not from hoping your technique stays identical over months of work.

The 15 μm boundary provides clear selection criterion: cells under 15 micrometers use S+ cassettes, cells over 15 micrometers use M+ cassettes. This boundary isn't arbitrary - it's where each aperture size achieves the optimal 15-40% cell-to-aperture ratio for signal quality and sizing resolution. Know your cell size, follow the boundary, and cassette selection becomes automatic.

Every AI-based image counter was trained on a specific dataset, learning to recognize "cell" and "not cell" from images someone curated. When your sample doesn't match that training set, physics-based counting tells a more reliable story.

The Precision Cell Systems Singulator provides automated, standardized tissue dissociation. But automation doesn't mean zero debris or guaranteed sample quality—integrating a Moxi QC checkpoint is what makes the workflow dependable.

Single-cell genomics workflows have a critical decision point: do you load this sample onto an expensive chip, or does it need more cleanup first? A preloading QC checkpoint answers that with confidence.

TIL counting and immune cell killing assays are immediate applications for dual-cassette workflows. Cancer cells are large, T cells are small - no single cassette optimizes both. Run S+ for accurate T cell counts, M+ for accurate tumor/target counts. The extra run takes minutes but delivers publication-quality E:T ratios and killing percentages.

New lab members need to generate valid data quickly. Teaching protocol optimization takes weeks. Teaching protocol execution takes minutes. The user manual is designed to be super easy - put X amount of viability reagent, put X amount of sample, incubate and go. When reagents are pre-optimized, training focuses on execution, not development.

Small cells measured through oversized apertures generate weak electrical signals that fall below detection thresholds or get confused with debris. If you're counting lymphocytes, PBMCs, Jurkat cells, or any suspension lines under 15 micrometers with the wrong cassette, you're likely undercounting. Switch to S+ cassettes where the smaller aperture ensures your small cells generate strong, detectable signals clearly distinguishable from noise.

Large cells approaching the aperture diameter create artificially high signals and risk clogging the sensing orifice. Clogging interrupts runs, wastes samples, and requires cassette replacement mid-experiment. For adherent cell lines like CHO, HEK293, and HeLa, and for primary tissue cells over 15 micrometers, M+ cassettes provide the larger aperture necessary to prevent physical blockage.

When your sample contains both small and large cells, no single cassette optimizes measurement for both populations. The solution: run the same sample twice - once with S+ to get accurate small cell counts, once with M+ to get accurate large cell counts. This dual-cassette workflow delivers accurate data for both populations rather than compromised data for everyone.

Coincidence - multiple cells in the aperture simultaneously - causes two cells to be counted as one, corrupting both count and size data. Optimal aperture utilization means targeting 15-40% of aperture diameter so cells generate strong signals while avoiding coincidence artifacts. Match your cassette to your cell size, stay within concentration guidelines, and coincidence becomes a non-issue.

Brain FFPE tissue creates unique nuclei isolation challenges. Myelin debris, lipid contamination, and fragile neuronal nuclei require controlled automated processing to preserve cell-type diversity for single-nucleus sequencing.

Process brain tumor FFPE from surgical resections on the Singulator 200+. Preserve cancer cells and immune populations for snRNA-seq and spatial analysis.

Extract nuclei from FFPE brain tissue for Alzheimer's, Parkinson's, and Lewy body research. Longitudinal cohorts, cell-type preservation, and disease staging on the Singulator 200+.

Pair spatial transcriptomics with snRNA-seq from the same FFPE brain block. Block allocation, platform selection, and nuclei quality for multi-omic brain studies.

Get high-quality nuclei from limited postmortem brain FFPE sections. Process NIH biobank allocations, hospital archives, and surgical specimens on the Singulator 200+.

Practical guide to postmortem brain FFPE challenges: necropsy timing, fixation variability, biobank sourcing, myelin debris, and how the Singulator 200+ standardizes nuclei extraction.

Standardize brain FFPE nuclei extraction across consortium sites with the Singulator 200+. Eliminate operator variability, prevent batch effects, and scale for atlas projects.

End-to-end protocol walkthrough from FFPE block selection through deparaffinization, nuclei isolation, quality control, library preparation, sequencing, and data analysis using the Singulator 200+.

How the Singulator 200+ GREEN cartridge automates FFPE deparaffinization and rehydration, eliminating toxic solvents, fume hoods, and manual ethanol series from nuclei extraction workflows.

Practical guide to connecting Singulator 200+ FFPE nuclei with downstream analysis platforms including 10x Chromium Flex, Xenium, ATAC-seq, Visium, and MERFISH, covering quality requirements, expected yields, and multi-platform study design.

Practical guide to preparing FFPE tissue inputs for the Singulator 200+ automated nuclei extraction platform, covering curl thickness selection, tissue mass requirements, block age effects, quality assessment, and handling difficult or precious specimens.

Practical troubleshooting guide for the Singulator 200+ FFPE nuclei extraction workflow, covering the five most common problem categories: low yield, excessive debris, poor RNA quality, batch-to-batch variability, and cartridge/instrument errors.

Practical strategies for maximizing nuclei recovery from limited FFPE tissue on the Singulator 200+, covering block quality assessment, sectioning waste reduction, the pilot curl approach for irreplaceable specimens, handling needle biopsies and crumbly blocks, and preserving nuclei yield post-processing.

Quality assessment of nuclei isolated from FFPE tissue using the Singulator 200+, covering yield measurement, DAPI staining for morphology, DV200 RNA quality metrics, erythrocyte contamination assessment, and structured go/no-go decision frameworks before downstream sequencing.

AI segmentation algorithms fail when encountering debris, clusters, or samples they were not trained on—resulting in minimum 3-4% error per image even under.

Every single-cell experiment represents a significant investment—consumables alone cost $500–1000+ per chip, plus downstream sequencing—so a confident go/no-go decision before chip commitment protects the run.